Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2024British Journal of Pharmacology

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy

View Full Paper
Ask AI
Bookmark
Share

Authors

WXWenjing XiangLLLei LiMQManman Qin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xiang et al. (2024) studied this question.

synapsesocial.com/papers/68e55ff7e2b3180350efca36https://doi.org/10.1111/bph.17347
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1not-yet-known not-yet-known not-yet-known unknown Diminished nuclear-localized β-adrenergic signaling activates YAP to promote kidney fibrosis in diabetic nephropathy2024
  2. 2Effects of (Pro)renin Receptor on Diabetic Cardiomyopathy Pathological Processes in Rats via the PRR-AMPK-YAP Pathway2021 · 25 citations
  3. 3Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencing2025 · 11 citations
  4. 4Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition <i>via</i> the TGF-β1-Smad3/7 pathway2026
  5. 5Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy2021 · 10 citations